Erlotinib Has Tumor Inhibitory Effect In Human Retinoblastoma Cells
Research indicates that Erlotinib effectively demonstrates a significant tumor inhibitory effect specifically within human retinoblastoma cells, suggesting its potential as a therapeutic agent for this eye cancer.